Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Advanced stages of PD: interventional therapies and related patient-centered care.

Krüger R, Hilker R, Winkler C, Lorrain M, Hahne M, Redecker C, Lingor P, Jost WH.

J Neural Transm. 2015 Jul 3. [Epub ahead of print]

PMID:
26138439
2.

Effects of PVA coated nanoparticles on human immune cells.

Strehl C, Gaber T, Maurizi L, Hahne M, Rauch R, Hoff P, Häupl T, Hofmann-Amtenbrink M, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2015 May 8;10:3429-45. doi: 10.2147/IJN.S75936. eCollection 2015.

3.

Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways.

Cheung CT, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, Blanchard JM, Lemmers B.

Carcinogenesis. 2015 May 19. pii: bgv069. [Epub ahead of print]

PMID:
25993989
4.

BAG3 regulates formation of the SNARE complex and insulin secretion.

Iorio V, Festa M, Rosati A, Hahne M, Tiberti C, Capunzo M, De Laurenzi V, Turco MC.

Cell Death Dis. 2015 Mar 12;6:e1684. doi: 10.1038/cddis.2015.53.

5.

APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.

García-Castro A, Zonca M, Florindo-Pinheiro D, Carvalho-Pinto CE, Cordero A, Gutiérrez del Fernando B, García-Grande A, Mañes S, Hahne M, González-Suárez E, Planelles L.

Carcinogenesis. 2015 May;36(5):574-84. doi: 10.1093/carcin/bgv020. Epub 2015 Mar 6.

PMID:
25750171
6.

In Silico Identification of Novel APRIL Peptide Antagonists and Binding Insights by Molecular Modeling and Immunosorbent Assays.

Silva JH, Calmon-Hamaty F, Savino W, Hahne M, Caffarena ER.

Protein Pept Lett. 2015;22(5):432-42.

PMID:
25731591
7.

Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients.

Lascano V, Hahne M, Papon L, Cameron K, Röeder C, Schafmayer C, Driessen L, van Eenennaam H, Kalthoff H, Medema JP.

Oncogenesis. 2015 Jan 26;4:e136. doi: 10.1038/oncsis.2014.50.

PMID:
25622308
8.

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

Spies CM, Hoff P, Mazuch J, Gaber T, Maier B, Strehl C, Hahne M, Jakstadt M, Huscher D, Burmester GR, Detert J, Kramer A, Buttgereit F.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.

PMID:
25535886
9.

Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?

Calmon-Hamaty F, Audo R, Combe B, Morel J, Hahne M.

Cytokine. 2014 Dec 3. pii: S1043-4666(14)00548-1. doi: 10.1016/j.cyto.2014.10.004. [Epub ahead of print] Review.

PMID:
25481649
10.

Effects of 60-day bed rest with and without exercise on cellular and humoral immunological parameters.

Hoff P, Belavý DL, Huscher D, Lang A, Hahne M, Kuhlmey AK, Maschmeyer P, Armbrecht G, Fitzner R, Perschel FH, Gaber T, Burmester GR, Straub RH, Felsenberg D, Buttgereit F.

Cell Mol Immunol. 2015 Jul;12(4):483-92. doi: 10.1038/cmi.2014.106. Epub 2014 Nov 10.

PMID:
25382740
11.

High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.

Daïen CI, Gailhac S, Audo R, Mura T, Hahne M, Combe B, Morel J.

Rheumatology (Oxford). 2015 Apr;54(4):601-8. doi: 10.1093/rheumatology/keu363. Epub 2014 Sep 16.

PMID:
25231180
12.

Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.

Rocha C, Papon L, Cacheux W, Marques Sousa P, Lascano V, Tort O, Giordano T, Vacher S, Lemmers B, Mariani P, Meseure D, Medema JP, Bièche I, Hahne M, Janke C.

EMBO J. 2014 Oct 1;33(19):2247-60. doi: 10.15252/embj.201488466. Epub 2014 Sep 1. Erratum in: EMBO J. 2014 Nov 18;33(22):2735.

PMID:
25180231
13.

Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.

Audo R, Calmon-Hamaty F, Papon L, Combe B, Morel J, Hahne M.

Arthritis Rheumatol. 2014 Dec;66(12):3289-99. doi: 10.1002/art.38806.

PMID:
25078097
14.

[Median nerve neuropathy after perilunate dislocation injuries].

Mühldorfer-Fodor M, Hohendorff B, Saalabian AA, Hahne M, van Schoonhoven J, Prommersberger KJ.

Handchir Mikrochir Plast Chir. 2014 Jun;46(3):163-8. doi: 10.1055/s-0034-1370959. Epub 2014 Jun 18. German.

PMID:
24940631
15.
16.

Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity.

Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, Morel J.

Arthritis Rheumatol. 2014 Aug;66(8):2037-46. doi: 10.1002/art.38666.

PMID:
24729478
17.

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model.

Lascano V, Guadagnoli M, Schot JG, Luijks DM, Guikema JE, Cameron K, Hahne M, Pals S, Slinger E, Kipps TJ, van Oers MH, Eldering E, Medema JP, Kater AP.

Blood. 2013 Dec 5;122(24):3960-3. doi: 10.1182/blood-2013-04-497693. Epub 2013 Oct 7.

18.

The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis.

Audo R, Combe B, Hahne M, Morel J.

Cytokine. 2013 Aug;63(2):81-90. doi: 10.1016/j.cyto.2013.04.011. Epub 2013 May 4. Review.

PMID:
23651570
19.

Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans.

Hoff P, Rakow A, Gaber T, Hahne M, Sentürk U, Strehl C, Fangradt M, Schmidt-Bleek K, Huscher D, Winkler T, Matziolis D, Matziolis G, Badakhshi H, Burmester GR, Duda GN, Perka C, Buttgereit F.

Bone. 2013 Jul;55(1):93-101. doi: 10.1016/j.bone.2013.03.020. Epub 2013 Apr 6.

PMID:
23571050
20.

Pathophysiological hypoxia affects the redox state and IL-2 signalling of human CD4+ T cells and concomitantly impairs survival and proliferation.

Gaber T, Tran CL, Schellmann S, Hahne M, Strehl C, Hoff P, Radbruch A, Burmester GR, Buttgereit F.

Eur J Immunol. 2013 Jun;43(6):1588-97. doi: 10.1002/eji.201242754. Epub 2013 May 17.

PMID:
23519896
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk